{
    "title": "Spain's Oryzon shares soar after US Cancer Institute agrees to test new drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11027473/Spains-Oryzon-shares-soar-US-Cancer-Institute-agrees-test-new-drug.html",
    "date": "2022-07-19",
    "keywords": [
        "company",
        "oryzon",
        "cancer",
        "drug",
        "iadademstat",
        "development",
        "july",
        "biopharma",
        "tuesday",
        "institute",
        "statement",
        "collaboration",
        "safety",
        "efficacy",
        "name",
        "research",
        "agreement",
        "nci",
        "validation",
        "lsd1",
        "inhibitor",
        "ceo",
        "carlos",
        "buesa",
        "announcement",
        "morning",
        "reporting",
        "christina",
        "thykjaer",
        "emma",
        "pinedo",
        "osmond"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}